Startups
2016
KOGENIX THERAPEUTICS INC (Previously Klogene SL)Developing gene therapy treatments for neurodegenerative diseases
Therapeutic strategy is based on increasing the level of Klotho protein in the brain
Company merged to Klogene Therapeutics (20-Dec-2017)
Therapeutic strategy is based on increasing the level of Klotho protein in the brain
Company merged to Klogene Therapeutics (20-Dec-2017)
Address
Charles Street 1, 02114 Boston, United States of America
CERCA ownership
Barcelona, Spain
2002
Vall d’Hebron Institut de Recerca (VHIR)
Other Catalan Public owners
Logo
Logo
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
Kogenix Therapeutics, Inc. is a pre-clinical stage gene therapy company developing novel treatments for neurodegenerative diseases...
Our scientific founders have deep expertise and over 80 years of combined experience in neuroscience and gene therapy...
Our scientific founders have deep expertise and over 80 years of combined experience in neuroscience and gene therapy...
Product description
The company’s therapeutic strategy is based on increasing the level of Klotho protein in the brain, using adeno-associated virus vectors (AAV) as the delivery mechanism for the Klotho gene. The first targeted indications are Alzheimer’s disease (AD) and multiple sclerosis (MS)...
Company Closed or Exit Year